Cutting edge: Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome

被引:210
作者
Tangye, SG
Phillips, JH
Lanier, LL
Nichols, KE
机构
[1] Centenary Inst Canc Med & Cell Biol, Newtown, NSW 2042, Australia
[2] Univ Sydney, Sydney, NSW 2006, Australia
[3] DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunol, Palo Alto, CA 94304 USA
[4] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Inst Canc Res, San Francisco, CA 94143 USA
[6] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
关键词
D O I
10.4049/jimmunol.165.6.2932
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
X-linked lymphoproliferative syndrome (XLP) is an immunodeficiency characterized by life-threatening infectious mononucleosis and EBV-induced B cell lymphoma. The gene mutated in XLP encodes SLAM (signaling lymphocytic activation molecule-associated protein)-associated protein (SAP), a small SH2 domain-containing protein. SAP associates with 2B4 and SLAM, activating receptors expressed by NK and T cells, and prevents recruitment of SH2 domain-containing protein tyrosine phosphatase-2 SHP-2) to the cytoplasmic domains of these receptors, The phenotype of XLP may therefore result from perturbed signaling through SAP-associating receptors, We have addressed the functional consequence of SAP deficiency on 2B4-mediated NK cell activation. Ligating 2B4 on normal human NK cells with anti-2B4 mAb or interaction with transfectants bearing the 2B4 Ligand CD48 induced NK tell cytotoxicity, In contrast, ligation of 2B4 on NK cells from a SAP-deficient XLP patient failed to initiate cytotoxicity. Despite this, CD2 or CD16-induced cytotoxicity of SAP-deficient NK tells was similar to that of normal NK cells, Thus, selective impairment of 2B4-mediated NK cell activation may contribute to the immunopathology of XLP.
引用
收藏
页码:2932 / 2936
页数:5
相关论文
共 34 条
[11]  
Kubota K, 1999, IMMUNOLOGY, V96, P491
[12]   NK cell receptors [J].
Lanier, LL .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :359-393
[13]   Regulation of immune responses through inhibitory receptors [J].
Long, EO .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :875-904
[14]  
MATHEW PA, 1993, J IMMUNOL, V151, P5328
[15]   An essential role for BLNK in human B cell development [J].
Minegishi, Y ;
Rohrer, J ;
Coustan-Smith, E ;
Lederman, HM ;
Pappu, R ;
Campana, D ;
Chan, AC ;
Conley, ME .
SCIENCE, 1999, 286 (5446) :1954-1957
[16]  
Nakajima H, 1999, EUR J IMMUNOL, V29, P1676, DOI 10.1002/(SICI)1521-4141(199905)29:05<1676::AID-IMMU1676>3.0.CO
[17]  
2-Y
[18]  
NAKAJIMA H, 2000, IN PRESS EUR J IMMUN
[19]   Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome [J].
Nichols, KE ;
Harkin, DP ;
Levitz, S ;
Krainer, M ;
Kolquist, KA ;
Genovese, C ;
Bernard, A ;
Ferguson, M ;
Zuo, L ;
Snyder, E ;
Buckler, AJ ;
Wise, C ;
Ashley, J ;
Lovett, M ;
Valentine, MB ;
Look, AT ;
Gerald, W ;
Housman, DE ;
Haber, DA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (23) :13765-13770
[20]   INTERLEUKIN-2 RECEPTOR GAMMA CHAIN MUTATION RESULTS IN X-LINKED SEVERE COMBINED IMMUNODEFICIENCY IN HUMANS [J].
NOGUCHI, M ;
YI, HF ;
ROSENBLATT, HM ;
FILIPOVICH, AH ;
ADELSTEIN, S ;
MODI, WS ;
MCBRIDE, OW ;
LEONARD, WJ .
CELL, 1993, 73 (01) :147-157